Genetic editing technologies present an ethical dilemma regarding equitable access. There exists the potential for widening the gap between different socio-economic groups, with only the wealthy having access to health-enhancing or disease-preventing modifications. This disparity raises ethical questions about fairness and the distribution of medical advancements, calling for frameworks that ensure these technologies benefit all segments of society.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.